最小重要差异在样本量计算中仅具最小重要性
本文论述随机对照试验样本量计算中假定获益的设定问题。作者指出,普遍认为应依据最小重要差异设定假定获益的观点是错误的;假定获益应设为真实获益的现实估计值,最小重要差异仅用于判断试验是否应开展。将二者调和会混淆有效与错误输入,导致实际把握度偏离目标把握度。
要点
- 最小重要差异不应作为设定假定获益的依据。
- 假定获益应设为真实获益的现实估计值。
- 若按现实估计值设计的试验不太可能证明存在有意义的获益,则不应开展该试验。
核心结论
- 当试验目的是检验无治疗获益的零假设时,最小重要差异的唯一作用应是判断样本量是否应为零,即试验是否应开展。
- 假定获益应设为真实获益的现实估计值;若按此设计的试验不太可能证明存在有意义的获益,则不应开展该试验。
- 在设定假定获益时试图调和现实获益估计与最小重要差异,只会混淆有效与基于错误输入的样本量计算,导致实际把握度无法匹配目标把握度。
研究设计与样本
- 本文为方法学论述,围绕随机对照试验样本量计算中假定获益的设定展开。
主要发现
- 普遍认为最小重要差异应用于设定假定获益并由此决定样本量,这一观点是错误的。
- 试验的真实把握度取决于真实获益,只有假定获益接近真实获益时,计算出的样本量才能得到接近目标把握度的真实把握度。
- 将现实获益估计与最小重要差异调和来设定假定获益,会混淆有效与基于错误输入的样本量计算,导致真实把握度无法匹配目标把握度。
关键数值与推荐
- 试验设计者计算样本量时应着力确定真实获益的合理估计值,而非判断多大获益幅度重要。
临床怎么用
- 原文未据此给出临床推荐。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Performing a sample size calculation for a randomized controlled trial requires specifying an assumed benefit (that is, the mean improvement in outcomes due to the intervention) and a target power. There is a widespread belief that judgments about the minimum important difference should be used when setting the assumed benefit and thus the sample size. This belief is misguided - when the purpose of the trial is to test the null hypothesis of no treatment benefit, the only role that the minimum important difference should be given is in determining whether the sample size should be zero, that is, whether the trial should be conducted at all.The true power of the trial depends on the true benefit, so the calculated sample size will result in a true power close to the target power used in the calculation only if the assumed benefit is close to the true benefit. Hence, the assumed benefit should be set to a value that is considered a realistic estimate of the true benefit. If a trial designed using a realistic value for the assumed benefit is unlikely to demonstrate that a meaningful benefit exists, the trial should not be conducted. Any attempt to reconcile discrepancies between the realistic estimate of benefit and the minimum important difference when setting the assumed benefit merely conflates a valid sample size calculation with one based on faulty inputs and leads to a true power that fails to match the target power.When calculating sample size, trial designers should focus efforts on determining reasonable estimates of the true benefit, not on what magnitude of benefit is judged important.
引用
- Wong H. Minimum important difference is minimally important in sample size calculations. Trials. 2023. PMID: 36650587. doi:10.1186/s13063-023-07092-8
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。